Evidence map›Paper›PMID 20866105›Full record

ArticleBiochemistry2010

Structure and mechanism of ORF36, an amino sugar oxidizing enzyme in everninomicin biosynthesis .

Jessica L Vey, Ahmad Al-Mestarihi, Yunfeng Hu, Michael A Funk, Brian O Bachmann, T M Iverson

Abstract read
In one paragraph

Article in Biochemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Structure of DnmZ, a nitrososynthase in the Streptomyces peucetius anthracycline biosynthetic pathway.Acta crystallographica. Section F, Structural biology communications · 2015
    Article
  7. Bioactive oligosaccharide natural products.Natural product reports · 2014
    Review
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jessica L VeyDepartment of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Ahmad Al-Mestarihi
Yunfeng Hu
Michael A Funk
Brian O Bachmann
T M Iverson

Funding

Complexities of complex II: A versatile architecture for respirationR01GM079419 · NIGMS · VANDERBILT UNIVERSITY · PI IVERSON, T M · 2007 to 2011
$1.3M
Biosynthesis of Hypotensive Phosphonopeptide Natural ProductsR01GM077189 · NIGMS · VANDERBILT UNIVERSITY · PI BACHMANN, BRIAN O · 2006 to 2010
$1.1M
NIGMS NIH HHS GM077189NIGMS NIH HHS R01 GM077189NIGMS NIH HHS R01 GM079419
6 · The paper itself

Abstract

Everninomicin is a highly modified octasaccharide that belongs to the orthosomycin family of antibiotics and possesses potent Gram-positive antibiotic activity, including broad-spectrum efficacy against multidrug resistant enterococci and Staphylococcus aureus. Among its distinctive structural features is a nitro sugar, l-evernitrose, analogues of which decorate a variety of natural products. Recently, we identified a nitrososynthase enzyme encoded by orf36 from Micromonospora carbonacea var. africana that mediates the flavin-dependent double oxidation of synthetically generated thymidine diphosphate (TDP)-l-epi-vancosamine to the corresponding nitroso sugar. Herein, we utilize a five-enzyme in vitro pathway both to verify that ORF36 catalyzes oxidation of biogenic TDP-l-epi-vancosamine and to determine whether ORF36 exhibits catalytic competence for any of its biosynthetic progenitors, which are candidate substrates for nitrososynthases in vivo. Progenitors solely undergo single-oxidation reactions and terminate in the hydroxylamine oxidation state. Performing the in vitro reactions in the presence of (18)O(2) establishes that molecular oxygen, rather than oxygen from water, is incorporated into ORF36-generated intermediates and products and identifies an off-pathway product that correlates with the oxidation product of a progenitor substrate. The 3.15 Å resolution X-ray crystal structure of ORF36 reveals a tetrameric enzyme that shares a fold with acyl-CoA dehydrogenases and class D flavin-containing monooxygenases, including the nitrososynthase KijD3. However, ORF36 and KijD3 have unusually open active sites in comparison to these related enzymes. Taken together, these studies map substrate determinants and allow the proposal of a minimal monooxygenase mechanism for amino sugar oxidation by ORF36.

Indexed as

AminoglycosidesAmino SugarsAnti-Bacterial AgentsCrystallography, X-RayMetabolic Networks and PathwaysMicromonosporaMixed Function OxygenasesOxidation-ReductionAminoglycosidesAmino SugarsAnti-Bacterial AgentsevernimicinMixed Function Oxygenases

Identifiers

PMID20866105
PMCPMC2964426

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.